Skip to content
healthcare.dev

Ranolazine

NDC 63629-4874, Ranolazine, tablet, extended release, from Bryant Ranch Prepack.

Product NDC
63629-4874
Status
Listed
Labeler
Bryant Ranch Prepack
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210188
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63629-4874 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RANOLAZINE500 mg/1

Pharmacologic classes

Anti-anginal [EPC]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
63629-4874-16362948740160 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-4874-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2e678c80-1410-433b-8c48-4b210eceb0de

Use it

Look up 63629-4874 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63629-4874 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63629-4874. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.